Table 10. Antiretroviral Components or Regimens Not Recommended as Initial Therapy Read more about Table 10. Antiretroviral Components or Regimens Not Recommended as Initial Therapy
Drug Interactions Between HIV-1 gp120-Directed Attachment Inhibitors and Other Drugs (Including Antiretroviral Agents) Read more about Drug Interactions Between HIV-1 gp120-Directed Attachment Inhibitors and Other Drugs (Including Antiretroviral Agents)
Nucleoside Reverse Transcriptase Inhibitor Options as Part of Initial Therapy Read more about Nucleoside Reverse Transcriptase Inhibitor Options as Part of Initial Therapy
Integrase Strand Transfer Inhibitor–Based Regimens Read more about Integrase Strand Transfer Inhibitor–Based Regimens
Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens Read more about Non-Nucleoside Reverse Transcriptase Inhibitor-Based Regimens
Table 7. Antiretroviral Regimen Considerations for Initial Therapy Based on Specific Clinical Scenarios Read more about Table 7. Antiretroviral Regimen Considerations for Initial Therapy Based on Specific Clinical Scenarios
Other Antiretroviral Regimens for Initial Therapy When Abacavir, Tenofovir Alafenamide, and Tenofovir Disoproxil Fumarate Cannot Be Used or Are Not Optimal Read more about Other Antiretroviral Regimens for Initial Therapy When Abacavir, Tenofovir Alafenamide, and Tenofovir Disoproxil Fumarate Cannot Be Used or Are Not Optimal
Table 9. Advantages and Disadvantages of Antiretroviral Components Recommended as Initial Antiretroviral Therapy Read more about Table 9. Advantages and Disadvantages of Antiretroviral Components Recommended as Initial Antiretroviral Therapy
